Summary
Nature’s Sunshine, a wellness products company listed on the NASDAQ under the ticker symbol NATR, has reported impressive Q3 CY2025 financial results. The company surpassed Wall Street’s revenue expectations with sales up 12% year-on-year to $128.3 million, exceeding analyst estimates by 6.7%. Additionally, Nature’s Sunshine’s non-GAAP profit of $0.36 per share was significantly above analysts’ consensus estimates. With its full-year revenue guidance revised upward and EBITDA guidance also higher than expected, investors are eager to know if this is a good time to invest in the company.
A Strong Quarter with Impressive Growth
Revenue growth was a significant highlight of Nature’s Sunshine’s Q3 CY2025 performance, increasing by 12% year-on-year to $128.3 million. This impressive figure not only exceeded analyst estimates but also reflects the company’s ability to maintain its sales momentum despite market fluctuations. The company’s revenue guidance for the full year has been revised upward to $478 million at the midpoint, a 2.3% increase from previous estimates.
Key Highlights of Nature’s Sunshine’s Q3 CY2025 Financials
- Revenue: $128.3 million vs analyst estimates of $120.3 million (12% year-on-year growth, 6.7% beat)
- Adjusted EPS: $0.36 vs analyst estimates of $0.16 (significant beat)
- Adjusted EBITDA: $15.19 million vs analyst estimates of $10.49 million (11.8% margin, 44.8% beat)
Lifting Revenue and EBITDA Guidance
Nature’s Sunshine not only demonstrated strong growth in its current quarter but also provided a promising outlook for the full year. The company lifted its revenue guidance to $478 million at the midpoint from $467.5 million, representing a 2.2% increase. Similarly, its EBITDA guidance for the full year is now placed at $48 million at the midpoint, exceeding analyst estimates of $43.8 million.
Market Capitalization and Operating Margins
With a market capitalization standing at $249.2 million, Nature’s Sunshine continues to be a significant player in the wellness products market. The company’s operating margin improved significantly from 4.6% in the same quarter last year to 7%, reflecting its efficiency gains. Additionally, its free cash flow margin expanded to 13.1%, up from 6.9% in the corresponding period last year.
CFO Perspective on Q3 Results
Shane Jones, CFO of Nature’s Sunshine, commented on their strong performance, saying, "The momentum in our business continued to accelerate in the third quarter, with record net sales of $128 million and adjusted EBITDA of $15 million, representing year-over-year growth of 12% and 42%, respectively."
A Glance at Company Overview and Revenue Growth
Started on a kitchen table in Utah, Nature’s Sunshine manufactures and sells nutritional and personal care products. While its revenue has shown some growth over the years, it has faced challenges, particularly when compared to larger competitors benefiting from economies of scale and negotiating leverage with retailers.
A Breakdown of Nature’s Sunshine Quarterly Revenue Growth
- Revenue growth rate: 2.8% compounded annual growth rate (CAGR) over the last three years
- Current quarter revenue growth: 12%
- Analyst estimates for revenue over the next 12 months: 1%, a slight deceleration from previous years
Why Cash Flow Matters
Cash is king in any business, and investors should pay attention to whether a company generates enough free cash flow. Nature’s Sunshine has shown mediocre cash profitability over the last two years, which limits its ability to return capital to shareholders.
An Examination of Nature’s Sunshine Trailing 12-Month Free Cash Flow Margin
- Average free cash flow margin: 4.8%, subpar for a consumer staples business
- Margins expanded by 3.7 percentage points over the last year, reflecting efforts by the company
Conclusion from Q3 CY2025 Results
Despite beating analysts’ revenue, EPS, and EBITDA expectations this quarter, Nature’s Sunshine may not be a good investment opportunity right now based solely on its Q3 performance. The stock might have had a great quarter, but it’s crucial to consider the bigger picture of valuation, business qualities, and the latest earnings before making any decisions.
This in-depth analysis is available in our full research report, which provides an actionable look at Nature’s Sunshine’s prospects, including valuation, business quality, and recent earnings.